On June 5, MicroPort Robot-B rose 5.16% in regular trading, reaching HKD 25.62, with trading volume of HKD 119 million.
On the news front, the company's independently developed Toumai surgical robot was personally experienced and publicly endorsed by Brazil's president. The system has been approved for large-scale remote surgery deployment within Brazil's Unified Public Health System (SUS), with the first batch of surgeries scheduled for July. Currently, Toumai robot global orders cover nearly 60 countries, with remote surgery applications extending to over 20 nations across Asia, Europe, Africa, and Latin America, marking a significant acceleration in international commercialization.
MicroPort Robot is primarily engaged in the R&D, manufacturing, and sales of surgical robots. Its product portfolio covers laparoscopic, orthopedic, pan-vascular, trans-natural orifice, and percutaneous puncture surgical fields. The Brazil milestone represents a major step in the company's strategy to penetrate emerging markets through government healthcare systems.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments